Eflapegrastim not checked

Spectrum Pharmaceuticals, Inc · SPI-2012 · HM10460A

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 2 trial completes
Trials
1 active
5 in total

What this is

How it works
Leukocyte Growth Factor FDA class
How it’s given
“Eflapegrastim supplied in prefilled, single-use syringes for SC injection.”In the company’s words, NCT04570423 on ClinicalTrials.gov
Tested for
Solid Tumors, Lymphoma
Main trialPhase 2
“The purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma and treated with myelosuppressive chemotherapy.”In the company’s words, NCT04570423 on ClinicalTrials.gov
Other names
SPI-2012 · Rolontis · HM10460A

Other drugs for Solid Tumors

All 2439 drugs for Solid Tumors

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials5

TrialPhaseCompletesWhat it tests
Phase 2Recruiting Oct 2027 A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
Phase 3Completed 24 Jan 2018 SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)
Phase 3Completed 8 Jun 2018 SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide
Phase 2Completed 12 Aug 2014 Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer
Phase 1Completed 16 Jul 2024 Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Eflapegrastim

Following is part of Solo: you see every change to Eflapegrastim the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in